| Product containing precisely doravirine 100 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) | | Doravirine 100 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet |
| | Id | 1304211000 | | Status | Defined |
| Has BoSS | Lamivudine | | Has precise active ingredient | Lamivudine | | Has presentation strength denominator unit | Tablet | | Has presentation strength numerator unit | mg |
| Has BoSS | Doravirine | | Has precise active ingredient | Doravirine | | Has presentation strength denominator unit | Tablet | | Has presentation strength numerator unit | mg |
|